Cryoport, Inc. (CYRX) has a MoatMap StockRank of 70/100 based on Quality (31/100), Value (53/100), and Momentum (70/100) factor scores. The current signal is BUY. Temperature-controlled logistics provider with low quality metrics and high capital intensity, failing to meet our concentrated portfolio standards.
Cryoport, Inc. is a leading provider of advanced cold chain logistics solutions for the life sciences industry, specializing in the temperature-controlled transport of high-value biological materials, including cell and gene therapies. Its competitive moat is built on proprietary cryogenic shipping technology, specialized logistics expertise, and a global network, positioning it as an indispensable partner for biotech and pharmaceutical companies.
| Price | $15.65 |
| Market Cap | $769M |
| P/E (Forward) | -26.06 |
| Price/Book | 1.80 |
| Return on Equity | -8.2% |
| Return on Invested Capital | -5.5% |
| Debt/Equity | 46.56 |
| Gross Margin | 47.2% |
| Operating Margin | -20.1% |
| Revenue Growth | 16.5% |
| Free Cash Flow | $65M |
Cryoport, Inc. operates in the Integrated Freight & Logistics industry, part of the Industrials sector (United States).